⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001855251

Eliades George Christopher

Reports to the SEC for 1 company · PRINCETON, NJ

Transactions

10

Companies

1

Filings

4

CIK

0001855251

Forms 4 and 5

Insider transactions

10 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−11.8K sh	—	—	16,863
2023-01-03	Oyster Point Pharma, Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−16.9K sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,199 sh	—	—	0
2023-01-03	Oyster Point Pharma, Inc.Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,359 sh	—	—	0
2022-06-06	Oyster Point Pharma, Inc.A Award	Director	AAward	+3,573 sh	—	—	28,624
2022-06-06	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,359 sh	—	—	5,359
2021-06-07	Oyster Point Pharma, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+5,199 sh	—	—	5,199
2021-06-07	Oyster Point Pharma, Inc.A Award	Director	AAward	+3,466 sh	—	—	25,051
2021-04-02	Oyster Point Pharma, Inc.A Award	Director	AAward	+19.9K sh	—	—	19,935
2021-04-02	Oyster Point Pharma, Inc.A Award	Director	AAward	+1,650 sh	—	—	21,585

Recent filings

4

Accepted (ET)
Jan 44
Eliades George Christopher0001209191-23-001065
SEC(opens sec.gov)
Jun 84
Eliades George Christopher0001209191-22-035065
SEC(opens sec.gov)
Jun 94
Eliades George Christopher0001209191-21-039348
SEC(opens sec.gov)
Apr 54
Eliades George Christopher0001209191-21-025490
SEC(opens sec.gov)

Companies

1

Oyster Point Pharma, Inc.Director

Address

C/O OYSTER POINT PHARMA, INC. 202 CARNEGIE CENTER, SUITE 109

PRINCETON, NJ, 08540